Nutra Pharma NPHC
OTC NPHC
$0.00 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Nutra Pharma Corp (NPHC) Current Deferred Revenue (2017 - 2024)

Updated

Nutra Pharma (NPHC) recorded Current Deferred Revenue of $287,509 in Q3 2024, down 20.2% from $360,149 a year earlier but up 26.2% from the prior quarter.

Analysis

Nutra Pharma Corp (NPHC) Current Deferred Revenue (2017 - 2024) Analysis & Trends

At the end of FY2023, Nutra Pharma reported Current Deferred Revenue of $233,331, up 28.5% from FY2022.

  • Across earlier years, Current Deferred Revenue came in at $181,515 in FY2022.
  • Quarterly Current Deferred Revenue has ranged from $80,410 in Q2 2022 to $360,149 in Q3 2023 over the past five years.
  • On a year-over-year basis, Current Deferred Revenue has declined for three consecutive quarters, with growth averaging 79.2% over the last six quarters.
  • Per Business Quant, the preceding three quarters came in at $227,762 (Q2 2024), $228,306 (Q1 2024) and $233,331 (Q4 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 287,509.00
Jun 30, 2024 227,762.00
Mar 31, 2024 228,306.00
Dec 31, 2023 233,331.00
Sep 30, 2023 360,149.00
Jun 30, 2023 312,173.00
Mar 31, 2023 281,417.00
Dec 31, 2022 181,515.00
Sep 30, 2022 111,011.00
Jun 30, 2022 80,410.00
Mar 31, 2018 12,490.00
Dec 31, 2017 22,490.00
API Access

Nutra Pharma Corp Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NPHC&period=max&api_key=YOUR_API_KEY